What is Incannex Healthcare Ltd ADR (IXHL) stock price today?

Incannex Healthcare Ltd ADR (IXHL) currently trades at $4.39 per share. The stock has a market capitalization of $56.87M and a P/E ratio of —x.

Is IXHL stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Incannex Healthcare Ltd ADR has a Smart Value Score of 24/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -16.69.

Is Incannex Healthcare Ltd ADR financially healthy?

Incannex Healthcare Ltd ADR's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -16.69 places it in the distress.

IXHL

Incannex Healthcare Ltd ADR

NASDAQ: IXHL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$4.39

+11.99% today

Updated 2026-04-30

Market cap

$56.87M

P/E ratio

—

P/S ratio

7,764.11x

EPS (TTM)

$-22.20

Dividend yield

—

52W range

$2 – $50

Volume

2.7M

Market cap

$56.87M

P/E ratio

—

P/S ratio

7,764.11x

EPS (TTM)

$-22.20

Dividend yield

—

52W range

$2 – $50

Volume

2.7M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-16.7

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.00x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -16.69 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-9.22M

- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$540170.00	$1.01M	$17965.00	$86000.00	$0.00
Net income	$-10.25M	$-48.81M	$-27.63M	$-46.88M	$-6.52M
EPS	—	—	—	—	$-22.20
Free cash flow	$-8.84M	$-11.06M	$-16.12M	$-12.52M	$-9.22M
Profit margin	-1,898.02%	-4,814.28%	-153,826.71%	-54,517.44%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IXHL	$56.87M	24	2.7	3.0	5.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Incannex Healthcare Ltd ADR trades at $4.39. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -16.69, it sits in the distress.

Frequently asked questions

What is Incannex Healthcare Ltd ADR's stock price?

Incannex Healthcare Ltd ADR (IXHL) trades at $4.39.

Is Incannex Healthcare Ltd ADR overvalued?

Smart Value Score 24/100 (Grade F, Strong Sell).

What is the price target of Incannex Healthcare Ltd ADR (IXHL)?

The analyst target price is $—, representing NaN% downside from the current price of $4.39.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-16.69 — distress.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.incannex.com

Quick metrics

P/S ratio7,764.11x

ROE-130.40%

Beta2.73

50D MA$4.22

200D MA$11.19

Shares out0.01B

Float0.01B

Short ratio—

Avg volume2.7M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

IXHL vs LLY →IXHL vs JNJ →IXHL vs ABBV →Stock screener →